ABEONA THERAPEUT. DL-01 (PCJ) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.113x

Based on the latest financial reports, ABEONA THERAPEUT. DL-01 (PCJ) has a cash flow conversion efficiency ratio of -0.113x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-17.95 Million ≈ $-20.99 Million USD) by net assets (€159.22 Million ≈ $186.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see PCJ market cap for the company's overall valuation and market capitalisation.

ABEONA THERAPEUT. DL-01 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how ABEONA THERAPEUT. DL-01's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ABEONA THERAPEUT. DL-01 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ABEONA THERAPEUT. DL-01 ranked by their cash flow conversion efficiency. Explore ABEONA THERAPEUT. DL-01 cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
American Battery Technology Company Common Stock NASDAQ:ABAT	-0.082x
Sight Sciences Inc NASDAQ:SGHT	-0.136x
Ananti Inc KQ:025980	0.009x
Arqit Quantum Inc. NASDAQ:ARQQ	-0.886x
Vátryggingafélag Íslands hf IC:SKAGI	0.083x
Anhui Huangshan Capsule Co Ltd SHE:002817	0.046x
NICE Holdings Co. Ltd KO:034310	0.070x
First Northern Community Bancorp Common stock NASDAQ:FNRN	0.016x

Annual Cash Flow Conversion Efficiency for ABEONA THERAPEUT. DL-01 (2021–2025)

The table below shows the annual cash flow conversion efficiency of ABEONA THERAPEUT. DL-01 from 2021 to 2025. View current stock price of ABEONA THERAPEUT. DL-01 for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€159.22 Million ≈ $186.14 Million	€-76.33 Million ≈ $-89.23 Million	-0.479x	+62.32%
2024-12-31	€44.03 Million ≈ $51.48 Million	€-56.02 Million ≈ $-65.49 Million	-1.272x	+49.04%
2023-12-31	€14.83 Million ≈ $17.33 Million	€-37.01 Million ≈ $-43.27 Million	-2.496x	-53.63%
2022-12-31	€26.76 Million ≈ $31.29 Million	€-43.48 Million ≈ $-50.84 Million	-1.625x	-4.84%
2021-12-31	€42.37 Million ≈ $49.53 Million	€-65.67 Million ≈ $-76.77 Million	-1.550x	--

About ABEONA THERAPEUT. DL-01

F:PCJ Germany Biotechnology

Market Cap

$318.74 Million

€272.64 Million EUR

Market Cap Rank

#15198 Global

#1487 in Germany

Share Price

€4.79

Change (1 day)

+4.33%

52-Week Range

€3.56 - €6.36

All Time High

€17.73